Hyaluronidase in the office: A necessity for every dermasurgeon that injects hyaluronic acid

Journal of Cosmetic and Laser Therapy

Volumn 9, Issue 3, 2007, Pages 182-185

  Hirsch, Ranelle J ^a,d   Brody, Harold J ^b   Carruthers, Jean D A ^c  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d Skincare Doctors   (United States)

Author keywords

Dermal fillers; Hyaluronic acid; Hyaluronidase; Soft tissue augmentation

Indexed keywords

ACETYLSALICYLIC ACID; GLYCERYL TRINITRATE; HYALURONIDASE;

ADULT; AGING; ARTICLE; CASE REPORT; DERMATOLOGY; FEMALE; FOREIGN BODY REACTION; GRANULOMATOSIS; HUMAN; NECROSIS; PRIORITY JOURNAL; RISK ASSESSMENT; SKIN SURGERY; THROMBOSIS;

COSMETIC TECHNIQUES; FEMALE; HUMANS; HYALURONIC ACID; HYALURONOGLUCOSAMINIDASE; INJECTIONS;

EID: 34548303279     PISSN: 14764172     EISSN: 14764180     Source Type: Journal    
DOI: 10.1080/14764170701291674     Document Type: Article

References (15)

1. Suhai B, Horvath G. How well does the Rayleigh model describe the E-vector distribution of skylight in clear and cloudy conditions? A full-sky polarimetric study. J Opt Soc Am A Opt Image Sci Vis. 2004;21:1669-76.
2. Anderson RR. Rest azured? J Am Acad Dermatol. 2001;44:874-5.
3. Hirsch RJ, Narurkar V, Carruthers JDA. Management of injected hyaluronic acid induced Tyndall effects. Lasers Surg Med. 2006;38:202-4.
4. Lambros V. The use of hyaluronidase to reverse the effects of hyaluronic acid filler. Plast Reconstr Surg. 2004;114:277.
5. Brody HJ. Use of hyaluronidase in the treatment of granulomatous hyaluronic acid reactions or unwanted hyaluronic acid misplacement. Derm Surg. 2005;31:8, 893-7.
6. Lowe NJ, Maxwell CA, Lowe P, Duick MG, Shah K. Hyaluronic acid skin fillers: Adverse reactions and skin testing. J Am Acad Dermatol. 2001;45:930-3.
7. Klein AW. Granulomatous foreign body reaction against hyaluronic acid. Dermatol Surg. 2004;30:1070.
8. Coleman SR. Avoidance of arterial occlusion from injection of soft tissue fillers. Aesthetic Surg J. 2002;22:555.
9. Schanz W, Schippert W, Ulmer A, Rassner G, Fierlbeck G. Arterial embolization caused by injection of hyaluronic acid (Restylane). Br J Dermatol. 2002;146:928-9.
10. Hirsch RJ, Cohen JL, Carruthers JDA. Successful Management of an Unusual Presentation of Impending Necrosis Following a Hyaluronic Acid Injection Embolus and a Proposed Algorithm for Management with Hyaluronidase. Dermatol Surg. 2007;33:357-60.
11. Glaich AS, Cohen JL, Goldberg LH. Injection necrosis of the glabella: Protocol for prevention and treatment after use of dermal fillers. Dermatol Surg. 2006;32: 285-90.
12. Hirsch RJ, Lupo M, Cohen JC, Duffy D. Delayed Presentation of Impending Necrosis Following Soft Tissue Augmentation with Hyaluronic Acid and Successful Management with Hyaluronidase. J Drugs Derm. 2007;6(3): 325-8.
13. Nathan N, Benrhaiem M, Lotfi H. The role of hyaluronidase on lidocaine and bupivicaine pharmacokinetics after peribulbar blockade. Anesth Analg. 1996;82:1060-4.
14. Dreizen NG, Framm L. Sudden unilateral visual loss after autologous fat injection into the glabellar area. Am J Ophthalmol. 1989;107:85-7.
15. Kirby B, Butt A, Morrison AM, Beck MH. Type I allergic reaction to hyaluronidase during ophthalmic surgery. Contact Dermatitis. 2001;44:52.